Genpact Limited (G) Stake Lowered by Logan Capital Management Inc.

Logan Capital Management Inc. trimmed its position in shares of Genpact Limited (NYSE:G) by 19.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 24,108 shares of the business services provider’s stock after selling 6,000 shares during the period. Logan Capital Management Inc.’s holdings in Genpact were worth $765,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of the company. American International Group Inc. bought a new position in Genpact in the fourth quarter worth about $114,000. Meeder Asset Management Inc. bought a new position in Genpact in the third quarter worth about $128,000. Advisor Group Inc. raised its stake in Genpact by 59.8% in the third quarter. Advisor Group Inc. now owns 5,017 shares of the business services provider’s stock worth $145,000 after buying an additional 1,878 shares in the last quarter. The Manufacturers Life Insurance Company raised its stake in Genpact by 7.5% in the second quarter. The Manufacturers Life Insurance Company now owns 6,508 shares of the business services provider’s stock worth $181,000 after buying an additional 455 shares in the last quarter. Finally, Verition Fund Management LLC bought a new position in Genpact in the second quarter worth about $210,000. 94.18% of the stock is owned by hedge funds and other institutional investors.

In other news, SVP Piyush Mehta sold 12,500 shares of the stock in a transaction that occurred on Monday, November 27th. The shares were sold at an average price of $32.00, for a total transaction of $400,000.00. Following the sale, the senior vice president now owns 77,944 shares in the company, valued at $2,494,208. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director James C. Madden sold 4,270 shares of the stock in a transaction that occurred on Thursday, February 15th. The shares were sold at an average price of $30.92, for a total transaction of $132,028.40. The disclosure for this sale can be found here. In the last 90 days, insiders sold 164,934 shares of company stock worth $5,346,881. Corporate insiders own 1.41% of the company’s stock.

Shares of Genpact Limited (NYSE:G) opened at $31.99 on Friday. The firm has a market cap of $6,083.63, a PE ratio of 20.89, a price-to-earnings-growth ratio of 2.03 and a beta of 0.57. The company has a quick ratio of 1.65, a current ratio of 1.65 and a debt-to-equity ratio of 0.77. Genpact Limited has a fifty-two week low of $23.34 and a fifty-two week high of $34.79.

Genpact (NYSE:G) last announced its quarterly earnings data on Monday, February 12th. The business services provider reported $0.43 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.41 by $0.02. The business had revenue of $734.41 million for the quarter, compared to analysts’ expectations of $723.55 million. Genpact had a net margin of 9.61% and a return on equity of 23.53%. The business’s revenue was up 7.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.43 earnings per share. equities analysts expect that Genpact Limited will post 1.55 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 21st. Shareholders of record on Friday, March 9th will be issued a $0.075 dividend. This represents a $0.30 dividend on an annualized basis and a yield of 0.94%. The ex-dividend date is Thursday, March 8th. This is a boost from Genpact’s previous quarterly dividend of $0.06. Genpact’s dividend payout ratio is 17.91%.

A number of equities analysts recently issued reports on the stock. Robert W. Baird reissued a “buy” rating and issued a $38.00 price target on shares of Genpact in a research note on Friday, November 10th. Cantor Fitzgerald reissued a “buy” rating and issued a $36.00 price target on shares of Genpact in a research note on Wednesday, November 8th. Citigroup decreased their price target on shares of Genpact from $39.00 to $37.50 and set a “buy” rating for the company in a research note on Tuesday, February 13th. Zacks Investment Research raised shares of Genpact from a “sell” rating to a “hold” rating and set a $35.00 price target for the company in a research note on Friday, November 10th. Finally, JPMorgan Chase & Co. decreased their price target on shares of Genpact from $38.00 to $37.00 and set a “neutral” rating for the company in a research note on Wednesday, February 14th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and eight have issued a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $34.65.

COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by The Lincolnian Online and is the property of of The Lincolnian Online. If you are viewing this piece of content on another website, it was stolen and republished in violation of international copyright and trademark laws. The correct version of this piece of content can be read at https://www.thelincolnianonline.com/2018/02/24/genpact-limited-g-stake-lowered-by-logan-capital-management-inc.html.

Genpact Profile

Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G).

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply